Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of$ 0.70. This compares to loss of $0.82 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.43%. A quarter ago, it was expected that this company would post a loss of$ 2.34 per share when it actually produced a loss of $2.35, delivering a surprise of -0.43%. Over the last four quarters, the compa ...